Horizon Pharma, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2013. For the quarter, the company expects total net revenues of $31.9 million to $32.4 million.

For the full year, the company expects total annual net revenues of $79.5 million to $80.0 million.